[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate

C96H88N22O5S — CID 158347987

IUPAC[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate
SMILESCOC(=O)C1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)ncnn23)CC1.Nc1nccn2c(C3CCC3)nc(-c3cc4ccccc4s3)c12.Nc1nccn2c(C3CCN(C(=O)C#Cc4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCN(C(=O)C4=Cc5ccccc5OC4)CC3)nc(-c3cc4ccccc4[nH]3)c12
InChIInChI=1S/C29H26N6O2.C28H24N6O.C21H22N6O2.C18H16N4S/c30-27-26-25(23-16-19-5-1-3-7-22(19)32-23)33-28(35(26)14-11-31-27)18-9-12-34(13-10-18)29(36)21-15-20-6-2-4-8-24(20)37-17-21;29-27-26-25(23-18-21-8-4-5-9-22(21)31-23)32-28(34(26)17-14-30-27)20-12-15-33(16-13-20)24(35)11-10-19-6-2-1-3-7-19;1-29-21(28)13-8-6-12(7-9-13)20-26-17(18-19(22)23-11-24-27(18)20)16-10-14-4-2-3-5-15(14)25-16;19-17-16-15(14-10-12-4-1-2-7-13(12)23-14)21-18(11-5-3-6-11)22(16)9-8-20-17/h1-8,11,14-16,18,32H,9-10,12-13,17H2,(H2,30,31);1-9,14,17-18,20,31H,12-13,15-16H2,(H2,29,30);2-5,10-13,25H,6-9H2,1H3,(H2,22,23,24);1-2,4,7-11H,3,5-6H2,(H2,19,20)
InChIKeyGRYVCHYQCTYDBZ-UHFFFAOYSA-N
MW1661.98 g/mol
LogP16.62
Rot. Bonds10

About [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate

[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate (PubChem CID 158347987) has the molecular formula C96H88N22O5S and a molecular weight of 1661.98 g/mol. Its IUPAC name is [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate.

Molecular Properties

Compound Name[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate
PubChem CID158347987
Molecular FormulaC96H88N22O5S
Molecular Weight1661.98 g/mol
Exact Mass1660.70
IUPAC Name[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate
SMILESCOC(=O)C1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)ncnn23)CC1.Nc1nccn2c(C3CCC3)nc(-c3cc4ccccc4s3)c12.Nc1nccn2c(C3CCN(C(=O)C#Cc4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCN(C(=O)C4=Cc5ccccc5OC4)CC3)nc(-c3cc4ccccc4[nH]3)c12
InChIInChI=1S/C29H26N6O2.C28H24N6O.C21H22N6O2.C18H16N4S/c30-27-26-25(23-16-19-5-1-3-7-22(19)32-23)33-28(35(26)14-11-31-27)18-9-12-34(13-10-18)29(36)21-15-20-6-2-4-8-24(20)37-17-21;29-27-26-25(23-18-21-8-4-5-9-22(21)31-23)32-28(34(26)17-14-30-27)20-12-15-33(16-13-20)24(35)11-10-19-6-2-1-3-7-19;1-29-21(28)13-8-6-12(7-9-13)20-26-17(18-19(22)23-11-24-27(18)20)16-10-14-4-2-3-5-15(14)25-16;19-17-16-15(14-10-12-4-1-2-7-13(12)23-14)21-18(11-5-3-6-11)22(16)9-8-20-17/h1-8,11,14-16,18,32H,9-10,12-13,17H2,(H2,30,31);1-9,14,17-18,20,31H,12-13,15-16H2,(H2,29,30);2-5,10-13,25H,6-9H2,1H3,(H2,22,23,24);1-2,4,7-11H,3,5-6H2,(H2,19,20)
InChIKeyGRYVCHYQCTYDBZ-UHFFFAOYSA-N
XLogP16.62
TPSA361.25 Ų
H-Bond Donors7
H-Bond Acceptors23
Rotatable Bonds10
Heavy Atoms124
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001661.98
LogP ≤ 516.62
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The IUPAC name of [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate (CID 158347987) is [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate.
What is the SMILES notation for [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The canonical SMILES for [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate is COC(=O)C1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)ncnn23)CC1.Nc1nccn2c(C3CCC3)nc(-c3cc4ccccc4s3)c12.Nc1nccn2c(C3CCN(C(=O)C#Cc4ccccc4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1nccn2c(C3CCN(C(=O)C4=Cc5ccccc5OC4)CC3)nc(-c3cc4ccccc4[nH]3)c12.
What is the InChIKey of [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The InChIKey is GRYVCHYQCTYDBZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H26N6O2.C28H24N6O.C21H22N6O2.C18H16N4S/c30-27-26-25(23-16-19-5-1-3-7-22(19)32-23)33-28(35(26)14-11-31-27)18-9-12-34(13-10-18)29(36)21-15-20-6-2-4-8-24(20)37-17-21;29-27-26-25(23-18-21-8-4-5-9-22(21)31-23)32-28(34(26)17-14-30-27)20-12-15-33(16-13-20)24(35)11-10-19-6-2-1-3-7-19;1-29-21(28)13-8-6-12(7-9-13)20-26-17(18-19(22)23-11-24-27(18)20)16-10-14-4-2-3-5-15(14)25-16;19-17-16-15(14-10-12-4-1-2-7-13(12)23-14)21-18(11-5-3-6-11)22(16)9-8-20-17/h1-8,11,14-16,18,32H,9-10,12-13,17H2,(H2,30,31);1-9,14,17-18,20,31H,12-13,15-16H2,(H2,29,30);2-5,10-13,25H,6-9H2,1H3,(H2,22,23,24);1-2,4,7-11H,3,5-6H2,(H2,19,20).
What are the key properties of [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate has a molecular weight of 1661.98 g/mol, XLogP of 16.62, 10 rotatable bonds, 7 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-(2H-chromen-3-yl)methanone;1-[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]piperidin-1-yl]-3-phenylprop-2-yn-1-one;1-(1-benzothiophen-2-yl)-3-cyclobutylimidazo[1,5-a]pyrazin-8-amine;methyl 4-[4-amino-5-(1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate is sourced from PubChem (CID 158347987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).